The antenatal screening market is projected to register a promising CAGR of 14% during the forecast period, up from US$ 2 Bn in 2022 to reach a valuation of US$ 7.2 Bn by 2032.
The antenatal screening market is anticipated to show promising growth prospects during the forecast period as a result of growing competition. New competitors are offering a variety of options at reasonable pricing to fulfill the demand for antenatal screening making it more accessible to customers, increasing the popularity of antenatal screening.
| Report Attribute | Details |
| Expected Market Value (2022) | US$ 2 Billion |
| Anticipated Forecast Value (2032) | US$ 7.2 Billion |
| Projected Growth Rate (2022-2032) | 14% CAGR |
Sales of antenatal screening are expected to rise significantly. In addition to this, demand for antenatal screening is rising on account for US$ 3.3 Bn by 2026.Demand for antenatal screening has become a widely acknowledged and well-established method that can continue for decades and has outstanding complication control. Around 700,000 women in the United Kingdom were pregnant in 2016. According to the UK National Screening Committee, almost 95% of these pregnancies resulted in normal birth, while the remainder had some type of complication.
It was discovered that the general growth and development of those unusual infants were impacted. With so many issues on the rise, the demand for antenatal screening will skyrocket, assisting in the detection of abnormalities and other disorders throughout pregnancy. The sales of antenatal screening tests performed during pregnancy can be made using ultrasound scans, blood tests, or a mix of both.
Manufacturers in the antenatal screening market get a big platform from which to serve the whole demand for antenatal screening. The worldwide sales of antenatal screening are seeing increased competition. With growing competition, new competitors are offering a variety of options at reasonable pricing, fulfilling the demand for antenatal screening more accessible to customers.
The majority of demand for antenatal screening requires selection, as diagnosis remains the sole invasive process for determining the risk of miscarriage. The two most common methods for the sales of antenatal screening techniques are amniocentesis and chorionic villus sampling (CVS).
Its goal is to give information that will assist in making decisions. There have recently been novel antenatal screening approaches that do not involve markers. The mother produces the majority of this kind of DNA, with the fetus/placenta producing roughly 15%.
Such demand for antenatal screening evaluates the proportion of DNA fragments from chromosome 21 in the maternal blood, and there is a modest increase when the fetus has Down syndrome. In modern obstetrics and gynecology, demand for antenatal screening is commonly employed, flourishing the sales of antenatal screening.
According to recent research studies, the most common pediatric health conditions that boosted the demand for antenatal screening are genetic disorders and congenital malformations. It has also been claimed that the majority of the fatalities seen account for more than a quarter of all deaths in the first year of life and are also caused by fatal anomalies. Screening for such clinical complexity would assist in expanding the antenatal screening market.
The antenatal screening market in North America is expected to be the largest contributor globally. The market is expected to develop rapidly as a result of the region's strong healthcare spending in disseminating awareness about sales of antenatal screening through print and other media.
Additionally, raising public awareness about the demand for antenatal screening would considerably aid market growth in the area. East and South Asia are expected to have the second-biggest share of the sales of antenatal screening, owing to the existence of the world's largest young population.
The next largest contributors to the global antenatal screening market will be Europe and Latin America. The antenatal screening markets in Oceania and the Middle East and Africa (MEA) will be the sixth and seventh biggest in the globe, respectively.
The MEA sales of antenatal screening market expansion might be hampered by the region's high poverty rate and religious influence, which prevents the bulk of the people from consuming urinary tract infection treatments.
The report consists of key players, contributing to the antenatal screening market share. It also consists of organic and inorganic growth strategies adopted by market players to improve their market positions. This exclusive report analyzes the competitive landscape and antenatal screening market share acquired by players to strengthen their market position.
GymnaUniphy, Biotec Italia srl, Cyronics Instruments Pvt.Ltd, Oakworks Med, India Viking ImpEx Private Ltd, Agilent Technologies Inc, PerkinElmer Inc. and others are some of the major competitors in the worldwide antenatal screening market.
Recent developments of the Antenatal Screening Market
| Report Attribute | Details |
| Growth rate | CAGR of 14% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2015 - 2021 |
| Forecast period | 2022 - 2032 |
| Quantitative units | Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Segments covered | Screening procedure type, indication, end user, region |
| Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
| Country scope | U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
| Key companies profiled | GymnaUniphy, Biotec Italia srl, Cyronics Instruments Pvt.Ltd, Oakworks Med, India Viking ImpEx Private Ltd, Agilent Technologies Inc, PerkinElmer Inc and others |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail of customized purchase options to meet your exact research needs. |
Based on Screening Procedure Type:
Based on Indication:
Based on End User:
Based on Region:
The antenatal screening market is predicted to register a CAGR of 14% during the forecast period.
Key players holding substantial antenatal screening market share include GymnaUniphy, Biotec Italia srl, Cyronics Instruments Pvt.Ltd, Oakworks Med, India Viking ImpEx Private Ltd, and others.
As per the analysis, the antenatal screening market share is likely to be US$ 3.3 Bn by 2026.
Demand for antenatal screening is likely to raise public awareness about the demand for antenatal screening would considerably aid market growth in the area.
Explore Similar Insights
Antenatal Screening Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
